EUVIMEDEUVIMED entdecken
Crossref

Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study

Sajad Jamalpour, Amin Alinezhad, Jinan Tuma Sabah, Reza Vazifehmand, Amir Barzegar Behrooz, Amir Syahir Amir Hamzah, Atiye Al-Sadat Davazdahemami, Foroozandeh Monem Homaie, Seyyedeh Mahdokht Maddah

Chemical and Pharmaceutical Bulletin · 2023

DOI: 10.1248/cpb.c22-00815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2023. Verfasst von Sajad Jamalpour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, University of Malaya. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansTemozolomideMolecular Docking Simulationbeta CateninGlycogen Synthase Kinase 3 betaWnt Signaling PathwayPaclitaxelCell Line, TumorDrug Resistance, NeoplasmGene ExpressionCell Proliferation

Stichwörter der Autor:innen

Wnt β-catenindrug combinationglioblastomapaclitaxeltemozolomide

Substanzen

Temozolomidebeta CateninGlycogen Synthase Kinase 3 betaPaclitaxel

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, University of Malaya.
  • Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences.
  • Department of Pathological Analysis, Faculty of Science, Wasit University.
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM).
  • Nano Biotechnology Research Group, Department of Biochemistry, Faculty of Biotechnology and Bimolecular Sciences, University Putra Malaysia.
  • Nanobiotechnology Research Group, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia.

Zitieren

APA

Jamalpour, S., Alinezhad, A., Sabah, J. T., Vazifehmand, R., Behrooz, A. B., Hamzah, A. S. A., Davazdahemami, A. A., Homaie, F. M., & Maddah, S. M. (2023). Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c22-00815

Vancouver

Jamalpour S, Alinezhad A, Sabah JT, Vazifehmand R, Behrooz AB, Hamzah ASA, et al. Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study. Chemical and Pharmaceutical Bulletin. 2023. doi:10.1248/cpb.c22-00815

BibTeX
@article{Jamalpour2023,
  author = {Jamalpour, Sajad and Alinezhad, Amin and Sabah, Jinan Tuma and Vazifehmand, Reza and Behrooz, Amir Barzegar and Hamzah, Amir Syahir Amir and Davazdahemami, Atiye Al-Sadat and Homaie, Foroozandeh Monem and Maddah, Seyyedeh Mahdokht},
  title = {Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2023},
  doi = {10.1248/cpb.c22-00815}
}
Kostenlos starten →